588 filings
Page 2 of 30
8-K
3l5t i6met5rwfkbi3mi
2 Jul 18
Submission of Matters to a Vote of Security Holders
7:00am
8-K
ozjtn2
27 Jun 18
Regulation FD Disclosure
8:00am
3
3rypqg1 pqvbuq
7 May 18
PROVECTUS BIOPHARMACEUTICALS / John Lacy III ownership change
7:11pm
3
dwwvp0sng2j47a4x6
7 May 18
PROVECTUS BIOPHARMACEUTICALS / Edward Pershing ownership change
5:47pm
DEFA14A
v81dv snp880qav85wjh
30 Apr 18
Additional proxy soliciting materials
12:00am
8-K
qb8p0h0w7
24 Apr 18
Provectus Biopharmaceuticals Announces Changes to Board of Directors
12:00am
8-K
g4ueu161ve05ldp28
6 Apr 18
Other Events
12:00am
8-K
bgddveqpbn
26 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
pvc4vg17ix i7kqw
22 Feb 18
Regulation FD Disclosure
12:00am
8-K
4f5qj2eqzqm jqm
30 Jan 18
Entry into a Material Definitive Agreement
12:00am
4
qa7 ti0og1szv1vlggg
18 Dec 17
PROVECTUS BIOPHARMACEUTICALS / John R Glass ownership change
12:00am
8-K
sdmyiaauh0v9gd rj5
12 Dec 17
PROVECTus Announces resolutIon of SEC investigation
12:00am
8-K
zsl65ypz
30 Nov 17
PROVECTus Announces Results from mechanism of action study of topical PH-10 for the Treatment of PSORIASIS
12:00am
8-K
36o6f xr9ky8pufd
18 Oct 17
Regulation FD Disclosure
12:00am
8-K
pnn9du8enc ct6s09ag
21 Sep 17
Regulation FD Disclosure
12:00am